FineMark National Bank & Trust’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-13,022
Closed -$527K 908
2016
Q4
$527K Buy
13,022
+446
+4% +$17.6K 0.04% 206
2016
Q3
$480K Buy
12,576
+2,345
+23% +$94.1K 0.05% 217
2016
Q2
$428K Buy
10,231
+1,926
+23% +$79K 0.05% 231
2016
Q1
$334K Buy
8,305
+1,635
+25% +$65.7K 0.04% 247
2015
Q4
$284K Sell
6,670
-36,415
-85% -$1.68M 0.03% 267
2015
Q3
$2.04M Buy
43,085
+8,399
+24% +$428K 0.28% 92
2015
Q2
$1.72M Buy
34,686
+21
+0.1% +$1.06K 0.22% 112
2015
Q1
$1.71M Buy
34,665
+9,121
+36% +$436K 0.23% 110
2014
Q4
$1.17M Sell
25,544
-6,288
-20% -$305K 0.17% 133
2014
Q3
$1.8M Buy
31,832
+3,871
+14% +$208K 0.29% 95
2014
Q2
$1.49M Buy
27,961
+7,971
+40% +$423K 0.25% 107
2014
Q1
$1.04M Buy
19,990
+2,501
+14% +$127K 0.2% 123
2013
Q4
$938K Buy
17,489
+5,825
+50% +$301K 0.19% 130
2013
Q3
$591K Buy
11,664
+3,211
+38% +$163K 0.15% 146
2013
Q2
$436K Buy
+8,453
New +$450K 0.13% 142

Other funds holding SNY

FineMark National Bank & Trust's SNY Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of Sanofi (SNY) in Q1 2017, closing a stake of 13,022 shares — an estimated $527K sold.

FineMark National Bank & Trust first reported a position in SNY in Q2 2013 and held it in 15 quarters. The position peaked at $2.04M in Q3 2015. 455 funds tracked by Wall St. Rank hold SNY as of Q1 2017.

  • FineMark National Bank & Trust reported no remaining Sanofi position as of Q1 2017 after selling out during the quarter.
  • FineMark National Bank & Trust sold 13,022 Sanofi shares in Q1 2017, an estimated $527K.
  • FineMark National Bank & Trust first reported a position in Sanofi in Q2 2013 and held it in 15 quarters.
  • FineMark National Bank & Trust's Sanofi position peaked at $2.04M in Q3 2015.
  • 455 funds tracked by Wall St. Rank held Sanofi as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.